Address
:
[Go to site:
main page
,
start
]
Usuń skrypty
Akceptuj cookies
Pokaż obrazy
Użyj Referer
Rotate13
Base64
Usu meta tagi
Usuń tytuł srony
Sesja cookies
Nouran's Substack
Subscribe
Sign in
Home
Notes
Archive
About
The Publication Bias in MEA Region is Real
Publication bias is not an academic problem. It is the hidden wall between a diagnosed patient and the treatment sitting in a warehouse they will never access.
READ THE LATEST
Latest
Top
Discussions
Your Rare Disease Drug Has Four Revenue Problems. A Conference Will Not Solve Any of Them.
The MEA rare disease commercial teams spending budget on physician events are solving the wrong problem. Here is what actually moves the needle, and why…
May 17
•
Nouran Hamza
2
One retraction after 281 citations and 500,000 reads. The pharma evidence crisis hiding in plain sight
The RWE Your Team Is Citing Right Now May Have the Same Problem as This Retracted Paper.
May 12
•
Nouran Hamza
1
Global Pharma Assume the Map Exists. We Had to Draw It.
2.8 million rare disease patients in MENA. No regional RWE framework. Our peer-reviewed regulatory review just changed that. Here is what took us there.
May 9
•
Nouran Hamza
3
The Peer-Reviewed Paper You Are Citing May Have Been Bought for USD 800 on Telegram. Nature Just Proved It.
Out of 53 papers found in indexed journals. 5 retracted, 1 withdrawn . 47 still live, still citable, still potentially inside your next SFDA submission.
May 6
•
Nouran Hamza
1
1
For every generation, vaccines work, Unless You Live in the Middle.
World Immunization Week 2026 celebrates 150 million lives saved. For millions of children and women across MENA, that celebration does not include them.
May 1
•
Nouran Hamza
3
1
We Call It Peer Review. Sometimes It Is Just Popularity
I tried to be calm in a webinar last week. A friend called me out. Here is what I actually think about how research funding works and who it is leaving…
Apr 25
•
Nouran Hamza
33
3
Is Your Real-World Evidence Actually Good Enough for GCC Market Access?
Most Medical Affairs teams in the Gulf are generating data. Far fewer are generating evidence that moves a committee. The difference is methodological…
Apr 22
•
Nouran Hamza
2
1
See all
Nouran's Substack
My personal Substack
Subscribe
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
